CXCL8 and non-small cell lung carcinoma: In non-small cell lung cancer (NSCLC) cells, YY1 binds directly to the promoter region of IL-8 and transcriptionally activates IL-8 expression, resulting in tumorigenesis and EGFR-TKIs resistance [32].